Novel admission hyperglycaemia markers as predictors of poor outcomes following percutaneous coronary interventions: a dose-response meta-analysis

Back

ESC2025 Premium Access

Novel admission hyperglycaemia markers as predictors of poor outcomes following percutaneous coronary interventions: a dose-response meta-analysis

Session: Biomarkers in acute coronary syndromes (2)

Topic: Biomarkers

Speaker: Mr P. Siahaan (Surabaya, ID)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Mr Paulus Siahaan

Airlangga University, Surabaya (Indonesia)

0 follower

7 more presentations in this session

Clonal Hematopoiesis of Indeterminate Potential (CHIP) mutations in patients with coronary artery disease

Speaker: Doctor N. Senguttuvan (Chennai, IN)

Albumin-based inflammation scores with integrated thrombotic markers outperform conventional predictors for mortality in acute coronary syndrome and atrial fibrillation

Speaker: Doctor H. Liang (Beijing, CN)

The clinical significance of misleading troponin elevations: is macrotroponin a culprit for unnecessary invasive coronary angiography?

Speaker: Mr A. Holst Kronborg (Copenhagen, DK)

Diagnostic and prognostic utility of neutrophil-to-lymphocyte ratio as a biomarker in patients with acute chest pain

Speaker: Mr B. Okamura (Basel, CH)

High frequency of macrotroponin i in the upper troponin range of a healthy reference population but no variation by age or sex

Speaker: Mrs N. Strandkjaer (Copenhagen, DK)

Access the full session

Biomarkers in acute coronary syndromes (2)

Speakers: Mr P. Siahaan, Doctor N. Senguttuvan, Doctor H. Liang, Mr A. Holst Kronborg, Mr B. Okamura...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources